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FULL-LENGTH ORIGINAL RESEARCH

Measurement equivalence of the newly developed Quality
of Life in Childhood Epilepsy Questionnaire (QOLCE-55)
*†‡§Mark A. Ferro, ¶**Shane W. Goodwin, ††Mark Sabaz, and ¶**‡‡Kathy N. Speechley
Epilepsia, 57(3):427–435, 2016
doi: 10.1111/epi.13296

SUMMARY

Dr. Mark Ferro is an
Assistant Professor at
McMaster University.

Objective: The aim of this study was to examine measurement equivalence of the
newly developed Quality of Life in Childhood Epilepsy Questionnaire (QOLCE-55)
across age, sex, and time in a representative sample of children with newly diagnosed
epilepsy.
Methods: Data come from 373 children enrolled in the Health-related Quality of Life
in Children with Epilepsy Study (HERQULES), a multisite prospective cohort study.
Measurement equivalence was examined using a multiple-group confirmatory factor
analysis framework, whereby increasingly stringent parameter constraints are
imposed on the model. Comparison groups were stratified based on age (4–7 years vs.
8–12 years), sex (male vs. female), and time (measurement of health-related quality of
life at diagnosis vs. 24 months later).
Results: The QOLCE-55 demonstrated measurement equivalence at the level of strict
invariance for each model tested—age: v2 (3,123) = 4,097.3, p < 0.001; Comparative
Fit Index (CFI) = 0.968; Root Mean Square Error of Approximation (RMSEA) = 0.042
(0.038, 0.045); sex: v2 (3,124) = 4,188.3, p < 0.001; CFI = 0.964; RMSEA = 0.044
(0.040, 0.047); and time: v2 (3,121) = 5,185.0, p < 0.001; CFI = 0.965; RMSEA = 0.046
(0.043, 0.048).
Significance: These findings suggest that items comprising the QOLCE-55 are perceived similarly among groups stratified by age, sex, and time and provide further evidence supporting the validity of the scale in children with epilepsy. Health
professionals and researchers should be confident that group comparisons made using
the QOLCE-55 are unbiased and that any group differences detected are meaningful;
that is, not related to differences in the interpretation of items by informants. Future
research replicating these findings is encouraged.
KEY WORDS: Factor analysis, Epilepsy, Health-related quality of life, Invariance,
Measurement, Rating scales.

Health-related quality of life (HRQoL) remains an important multidimensional clinical outcome and an active area
of research in pediatric epilepsy. Numerous studies have
shown that HRQoL, defined as the “subjective and objective
impact of dysfunction associated with an illness or injury,

medical treatment, and health care policy,”1 is compromised
in children with epilepsy.2,3 Because HRQoL is recognized
as one of the most important patient-reported outcomes,4
considerable effort has been aimed at developing measures
of HRQoL for children with epilepsy that are valid and
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Key Points
•
•
•

Demonstrating measurement equivalence is a key
component in scale development and evaluation
The QOLCE-55 demonstrates equivalence across age,
sex, and time in a representative sample of children
with newly diagnosed epilepsy
Group comparisons made using the QOLCE-55 are
unbiased; any differences are meaningful and unrelated to differences in item interpretation

reliable.5–9 Despite this progress, one aspect of scale
development has largely been ignored: measurement equivalence.
As an approach to empirically test the external validity of
a scale, measurement equivalence examines the extent to
which the psychometric properties of observed scale items
(i.e., questions) are generalizable across groups to determine if the same underlying construct, in this case, HRQoL,
is being measured in the same way.10 In other words, measurement equivalence tests whether questions asked of
respondents are interpreted similarly across groups so that
meaningful across-group comparisons can be made.
Although often assumed, evidence suggests that response
heterogeneity is common,11 and violation of the assumption
of measurement equivalence can lead to biased comparisons.12 If measurement equivalence of a scale is demonstrated, differences, either among groups or over time, can
be considered real and meaningful. However, without formally evaluating measurement equivalence, researchers and
clinicians cannot be certain whether observed differences
reflect true differences or whether they represent differences
in the interpretation of items or structure of the underlying
latent construct.10 Evidence of measurement nonequivalence would provide the motivation to develop new or modify existing measures of HRQoL to result in more
psychometrically sound measurement.
Although studies examining equivalence of HRQoL measures in children with epilepsy are nonexistent, some work
has been done in other measures of health in children with
epilepsy. One study found that the Attention and Thought
Problems subscales of the Child Behavior Checklist and
Youth Self Report demonstrated nonequivalence when
comparing children with and without epilepsy.13 Whereas
modeling the association between epilepsy and these behavior problems with the nonequivalent scales suggested that
children with epilepsy were at increased risk for attention
problems (b = 0.27; p < 0.001), removal of nonequivalent
items and computing the model with the equivalent scale
negated this association (b = 0.11; p = 0.417). The consequences of such biases with the use of patient-reported outcomes can result in misinformed medical decision making
Epilepsia, 57(3):427–435, 2016
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among health professionals and families, and in turn, poorer
health outcomes for children with epilepsy.
The objective of this study was to empirically test for
measurement equivalence of the newly developed 55-item
version of the Quality of Life in Childhood Epilepsy Questionnaire (QOLCE), an epilepsy-specific measure of
HRQoL.5 Measurement equivalence was tested between
groups stratified by age (4–7 years vs. 8–12 years), sex
(males vs. females), and time (measurement of HRQoL at
diagnosis vs. 24 months later), as prior studies have shown
associations between these variables and HRQoL in children with epilepsy.3,14–16

Methods
Data Source
Data come from 373 children enrolled in the HealthRelated Quality of Life of Children with Epilepsy Study
(HERQULES), a multisite prospective cohort of 4- to 12year-old children newly diagnosed with epilepsy. Children
were recruited from pediatric neurology outpatient clinics
and followed for 24 months with data collected at diagnosis
(baseline), and at 6, 12, and 24 months. At each of these
data collection time-points, parents completed a postal survey that measured the HRQoL of their child. In addition,
parents reported their own symptoms of depression, aspects
of the family environment related to stressors, functioning,
and resources, as well as sociodemographic information.
Pediatric neurologists provided clinical information
including type of epilepsy syndrome and seizures, seizure
frequency (low, moderate, high), and number of prescribed
antiepileptic medications. Presence of cognitive or behavioral problems in children was based on neurologists’ clinical experience measured using five-point and four-point
Likert scales, respectively. Lower scores represented no/
milder problems, and for this study, behavioral and cognitive problems were dichotomized as present or absent. In
addition, neurologists provided an assessment of the overall
severity of epilepsy using the Global Assessment of Severity of Epilepsy (GASE) scale.17,18 The GASE is a validated,
single-item, seven-point Likert scale that asks, “Taking into
account all aspects of this patient’s epilepsy, how would
you rate its severity at his/her last visit?” Response options
range from 1 = extremely severe to 7 = not at all severe.
Additional details of the HERQULES sample and methodology are available.3
Instrument
The QOLCE-55 is a modified version of the original
76-item QOLCE8,9 and provides an overall assessment of
parent-reported HRQoL of children with epilepsy aged
4–18 years of age across the four domains of HRQoL
(Fig. 1)—cognitive (22 items), emotional (17 items), social
(seven items), and physical (nine items). A five-point Likert
scale is used to rate items as follows: 0 = very often;
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Figure 1.
Higher-order Factor Structure of the
QOLCE-55. For simplicity, items
loading onto the first-order factors
are not shown. Individual items are
presented in Table S1.
Epilepsia ILAE

1 = fairly often; 2 = sometimes; 3 = almost never; and
4 = never. Ratings undergo linear transformation such that
total scores can take values from 0 (low HRQoL) to 100
(high HRQoL). The QOLCE-55 has excellent internal consistency reliability (a = 0.96). The QOLCE-55 and scoring
instructions are freely available.5
Procedure
Measurement equivalence of the QOLCE-55 was investigated using multiple-group confirmatory factor analysis.19
In this approach, increasingly stringent equality constraints
are specified for model parameters between groups (younger
vs. older age; male vs. female; and diagnosis vs. 24 months
later). For the younger versus older age comparison, the
sample was stratified to create groups that were as similar in
size as possible. This is because the v2 difference test (Dv2)
used in measurement equivalence testing is affected by gross
imbalances in group sizes that can result in biased inferences
surrounding model fit and the equivalence of a measure.10
For this study, younger children were those aged 4–7 years
(n = 178) and older children (i.e., preadolescents) were
those aged 8–12 years (n = 181). With regard to the longitudinal comparison, baseline data were compared to 24-month
data for participants who completed both measurement occasions (n = 275). As this was the longest follow-up available
in HERQULES, several participants (n = 86) transitioned
from childhood to preadolescence, and thus our tests of
measurement equivalence over time captured this important
developmental milestone. For the sex comparison, there
were 190 male and 169 female participants.
Guidelines for establishing measurement equivalence of
higher-order factor models composed of categorical
response items were followed.19,20 (1) Configural invari-

ance (model 1) imposed no equality constraints on parameters19 and was the origin for subsequent tests.21 (2) Weak
invariance (constrained factor loadings) examined the
extent to which the magnitude of the factor loadings (Λ) for
particular items (model 2) and first-order factors (model 3)
were equivalent between groups;10 it is a prerequisite for
making valid comparisons.22 (3) Strong invariance (constrained item thresholds/intercepts) tested for evidence that
item thresholds (m; model 4) and first-order factor intercepts
(s) are equivalent between groups (model 5).10 Strong
invariance verifies whether mean differences at the itemlevel are fully explained by mean differences at the higherorder factor-level. (4) Strict invariance (constrained residual
and factor variances) was performed to determine whether
the variances (h) of the regression equations for each item
(model 6) and first-order factors (model 7) were equivalent
across groups. Strict invariance is required for defensible
item-score comparisons (i.e., average item scores) between
groups.23
Evaluation and statistical analysis
Two criteria are required to establish measurement equivalence. First, model fit at each level of testing (i.e., configural, weak, etc.) must be adequate. It was determined a priori
that two of the three fit indices (v2 goodness-of-fit, Comparative Fit Index [CFI], Root Mean Square Error of Approximation [RMSEA]) needed to meet established cut-points to
declare adequate model fit.13, 24 The cut-points were: v2
goodness-of-fit p > 0.05; CFI > 0.900 is acceptable,
>0.950 is excellent; RMSEA < 0.08 is acceptable, <0.06 is
excellent.25–28 Second, change in fit indices from the less to
the more constrained model (e.g., configural to weak), must
not exceed established cut points for statistical or practical
Epilepsia, 57(3):427–435, 2016
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significance. Statistical significance was based on the Dv2
and practical significance on the DCFI and DRMSEA.
Again, it was determined a priori that the Dv2 and at least
one of the DCFI or DRMSEA scores needed to meet this criterion to establish measurement equivalence at any given
level of testing. The cut points for change in model fit
indices
were
Dv2
p > 0.001;
DCFI ≤ 0.010;
29
DRMSEA < 0.015. Statistical significance is supplemented by practical significance because the v2 difference
is strongly influenced by sample size, and thus inferences
related to measurement equivalence can be distorted.10 To
further reduce the effects of sample size on v2 difference
test, we used the more conservative a = 0.001 versus the
traditional a = 0.05 for statistical significance of equivalence testing.
Where measurement equivalence at a given level of testing was not established (i.e., significant worsening of model
fit), modification indices were reviewed to identify constraints on relevant nonequivalent parameters that could be
removed to improve model fit. The respecified model was
then tested against the less constrained model and change
scores for model fit computed. Freed parameters remained
unconstrained as measurement equivalence testing proceeded. This approach, known as partial equivalence,
argues that only a subset of model equivalent parameters are
needed for substantive analyses comparing group mean differences.30
Because the QOLCE-55 contains ordered categorical
response options, the confirmatory factor model used for
measurement equivalence testing was estimated using a
weighted least squares means and variance adjusted estimator.31 This estimator uses a diagonal weight matrix and pairwise deletion of missing data to generate robust parameter
estimates.32 Fourteen participants (4%) were excluded from
the analyses due to missing data on the QOLCE-55. Data
analysis was conducted using Mplus 6.11 (Muthen &
Muthen).

Results
Sample characteristics
The mean age of children was 7.5 (standard deviation,
2.3) years and 53% were male. Most had partial seizures
(62%), and cognitive and behavioral problems were
reported in 20% and 15%, respectively. Epilepsy was relatively benign; mean scores on the GASE and QOLCE-55
were 5.4 (1.2) and 71.1 (14.3), respectively, at baseline.
Based on the GASE, our sample would be described as
consisting primarily of children with “somewhat severe”
to “a little severe” epilepsy. Two thirds of children were
currently prescribed at least one antiepileptic drug. Two
thirds had seizure frequencies classified as low. Mothers
were the most common caregiver informant (93%). Families’ socioeconomic status was relatively high; most parents were in a partnered relationship (87%), had
Epilepsia, 57(3):427–435, 2016
doi: 10.1111/epi.13296

completed postsecondary education (66%), and were
employed (67%). Nearly 40% had annual household
incomes ≥$80,000. Sample characteristics by age and sex
are described in Table 1. Parents of younger children
were more likely to be younger (p < 0.001) and living in
a partnered relationship (p = 0.001) compared to parents
of older children. Compared to female children, male children were more likely to have partial seizures (p = 0.013)
and behavioral problems (p = 0.001).
Measurement equivalence by age
Prior to equivalence testing, independent models for
younger and older children were specified to verify adequate fitting baseline models with which to begin equivalence testing based on the established factor structure of the
QOLCE-55 (Fig. 1). Data fit the factor model well for both
the younger children: v2 (1,426) = 2,298.1, p < 0.001;
CFI = 0.948; RMSEA = 0.059 (0.054, 0.063); and preadolescent groups: v2 (1,426) = 2,109.6, p < 0.001;
CFI = 0.949; RMSEA = 0.051 (0.047, 0.056).
In the first step of testing, configural invariance, the factor structure of the QOLCE-55 was modeled simultaneously
in both younger children and preadolescents with no
parameter constraints. As shown in Table 2, model fit was
adequate according to the prespecified limits: v2
(2,857) = 4,486.7, p < 0.001; CFI = 0.946; RMSEA
= 0.056 (0.053, 0.060). At the level of weak invariance,
constraints were placed first on item factor loadings and
subsequently on first-order factor loadings. There was no
appreciable worsening of model fit in both instances (models 2 and 3). In the next stage of testing, strong invariance,
item thresholds, and then first-order intercepts were constrained between groups. Again, changes in the model-fit
indices were within limits to continue equivalence testing
(models 4 and 5). When item residuals were constrained at
the level of strict invariance (model 6), there was evidence
of nonequivalence [Dv2 (55) = 129.6, p < 0.001].
Modification indices suggested that removing the
constraints on following item residuals would improve
model fit: Had trouble understanding directions? (cognitive); Felt no one cared? (emotional); and Played with
friends away from you or your home? (physical). Once these
constraints were removed, change in model-fit indices were
acceptable [model 7: Dv2 (52) = 86.6; DCFI = 0.002;
DRMSEA = 0.001] and testing proceeded to constraining
factor variances. Measurement equivalence was established
at this final level of testing (model 8).
Measurement equivalence by sex
Baseline models for male: v2 (1,426) = 2,203.9,
p < 0.001; CFI = 0.951; RMSEA = 0.054 (0.049, 0.058);
and female participants: v2 (1,426) = 2,130.2, p < 0.001;
CFI = 0.950; RMSEA = 0.054 (0.049, 0.059) indicated
adequate fit to the factor model, and testing proceeded to
establish measurement equivalence between sexes.
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Table 1. Baseline sample characteristics stratified by age and sex
Young children 4–7
years (n = 178)

Preadolescents 8–12
years (n = 181)

Males
(n = 190)

Females
(n = 169)

5.5 (1.2)
56.0
62.3

9.5 (1.3)
49.2
58.6

7.4 (2.4)
–
67.4

7.6 (2.3)
–
54.8

64.1
21.5
14.4

67.6
19.2
13.2

66.0
21.1
12.9

66.5
19.3
14.2

36.0
59.4
4.6
17.7
14.1
5.4 (1.2)
70.5 (15.0)

30.4
67.9
1.6
21.6
15.7
5.5 (1.2)
71.8 (13.4)

30.0
66.5
3.6
22.6
21.2
5.4 (1.3)
70.9 (14.3)

37.3
59.9
2.8
16.4
8.4
5.4 (1.1)
71.7 (14.2)

36.0 (6.3)
91.4
91.4
66.7
64.9
34.6

39.3 (5.4)
94.1
81.8
66.3
69.2
42.8

37.3 (5.8)
91.8
89.2
69.2
67.4
38.6

38.1 (6.4)
93.8
83.7
63.5
66.7
38.8

Child characteristics
Age, years
Male, %
Partial seizures, %
Seizure frequency, %
Low
Moderate
High
No. AEDs currently prescribed, %
0
1
≥2
Cognitive problem, %
Behavior problem, %
Epilepsy severity, GASE
Health-related quality of life, QOLCE-55
Parent characteristics
Age, years
Female, %
Living with a partner, %
Postsecondary education, %
Employed, %
Household income ≥$80,000, %

AEDs, antiepileptic drugs. Continuous variables are reported as mean (standard deviation).

Table 2. Tests of measurement equivalence by age
Configural invariance
no constraints
Weak invariance I
item factor loadings
Weak invariance II
first-order factors
Strong invariance I
item thresholds
Strong invariance II
first-order intercepts
Strict invariance I
item residuals
Strict invariance I
item residuals (hCF1, hEF1, hPF1)
Strict invariance II
factor variances

v2 (df)

CFI

RMSEA (90% CI)

4,486.7 (2,857)

0.946

0.056 (0.053, 0.060)

4,502.9 (2,908)

0.947

0.055 (0.052, 0.058)

4,501.4 (2,911)

0.947

4,556.3 (3,062)

Dv2 (df)
–

DCFI

DRMSEA

–

–

64.5 (51)a

0.001

0.001

0.055 (0.052, 0.058)

3.7 (3)a

0.000

0.000

0.950

0.052 (0.049, 0.055)

152.1 (151)a

0.003

0.003

4,490.4 (3,066)

0.953

0.051 (0.048, 0.054)

2.2 (4)a

0.003

0.001

4,458.2 (3,121)

0.956

0.049 (0.046, 0.052)

129.6 (55)b

0.003

0.002

4,389.4 (3,118)

0.958

0.048 (0.044, 0.051)

86.6 (52)a

0.002

0.001

4,097.3 (3,123)

0.968

0.042 (0.038, 0.045)

5.8 (5)a

0.010

0.006

Children aged 4–7 years were in the “young child” group and those aged 8–12 in the “preadolescent” group. Italicized text describes the model parameters that
were constrained at each step of the testing process. Constraints on the residuals of item 1 in each of the Cognitive (CF1), Emotional (EF1), and Physical Functioning (PF1) domains were removed in model 7 to establish partial equivalence and remained unconstrained in subsequent models. aNot statistically significant;
b
p < 0.001.

As shown in Table 3, model fit at the level of configural
invariance was adequate according to the prespecified
limits: v2 (2,857) = 4,463.3, p < 0.001; CFI = 0.946;
RMSEA = 0.056 (0.053, 0.059). Similarly to tests between
younger and older children, equivalence was established to
the level of strong invariance (models 2 through 5). Again,

item residuals were constrained at the level of strict invariance (model 6), there was evidence of nonequivalence [Dv2
(55) = 110.9, p < 0.001]. Modification indices suggested
that removing the constraints on following item residuals
would improve model fit: Felt down or depressed? (emotional) and Played with friends away from you or your
Epilepsia, 57(3):427–435, 2016
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Table 3. Tests of measurement equivalence by gender
Configural invariance
no constraints
Weak invariance I
item factor loadings
Weak invariance II
first-order factors
Strong invariance I
item thresholds
Strong invariance II
first-order intercepts
Strict invariance I
item residuals
Strict invariance I
item residuals (hEF9, hPF1)
Strict invariance II
factor variances

v2 (df)

CFI

RMSEA (90% CI)

4,463.3 (2,857)

0.946

0.056 (0.053, 0.059)

4,482.3 (2,908)

0.947

0.055 (0.052, 0.058)

4,479.1 (2,911)

0.947

4,535.3 (3,062)

Dv2 (df)
–

DCFI

DRMSEA

–

–

67.8 (51)a

0.001

0.001

0.055 (0.052, 0.058)

1.0 (3)a

0.000

0.000

0.950

0.052 (0.049, 0.055)

157.8 (151)a

0.003

0.003

4,476.8 (3,066)

0.952

0.051 (0.047, 0.054)

3.4 (4)a

0.002

0.001

4,404.0 (3,21)

0.957

0.048 (0.045, 0.051)

110.9 (55)b

0.005

0.003

4,366.1 (3,119)

0.958

0.047 (0.044, 0.050)

85.4 (53)a

0.001

0.001

4,188.3 (3,124)

0.964

0.044 (0.040, 0.047)

13.2 (5)a

0.006

0.003

Italicized text describes the model parameters that were constrained at each step of the testing process. Constraints on the residuals of item 9 in the Emotional
Functioning domain (EF9) and item 1 in the Physical Functioning (PF1) domain were removed in model 7 to establish partial equivalence and remained unconstrained in subsequent models. aNot statistically significant; bp < 0.001.

home? (physical). Once these constraints were removed,
change in model fit indices were acceptable (model 7: Dv2
(53) = 85.4; DCFI = 0.001; DRMSEA = 0.001), and
testing proceeded to constraining factor variances that
demonstrated measurement equivalence at this final level of
testing (model 8).
Measurement equivalence over time
Baseline models at diagnosis—v2 (1,426) = 3,070.2,
p < 0.001; CFI = 0.944; RMSEA = 0.058 (0.056, 0.061)
and 24 months later: v2 (1,426) = 2,788.0, p < 0.001;
CFI = 0.952; RMSEA = 0.059 (0.056, 0.062)—indicated
adequate fit to the factor model and testing proceeded to
establish measurement equivalence over time (Table 4).
At the level of configural invariance, model fit for equivalence over time was adequate: v2 (2,858) = 5,923.7,
p < 0.001; CFI = 0.948; RMSEA = 0.058 (0.056, 0.061).
Strong invariance was achieved (models 2 through 5); however, the constraints on a number of residuals needed to be
removed to establish strict invariance (model 7): Had trouble understanding directions? (cognitive); Felt no one
cared? Felt excited or interested in something? Felt frustrated? (emotional); Limited his/her social activities (visiting friends, close relatives, or neighbors)? How limited are
your child’s social activities compared with others his/her
age? Frightened other people? (social); and Played with
friends away from you or your home? (physical). Likewise,
the constraint on the variance of Social Functioning
domain needed to be removed to strict invariance at the
higher order—model 9: Dv2 (4) = 17.7; DCFI = 0.000;
DRMSEA = 0.000. Parameter estimates for the final
age, sex, and time-equivalent models are shown in the
Table S1.
Epilepsia, 57(3):427–435, 2016
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Discussion
Using data from a prospective cohort study of children
newly diagnosed with epilepsy, measurement equivalence
was demonstrated for the QOLCE-55—a newly developed,
shorter version of the original scale measuring HRQoL in
children with epilepsy. These findings suggest that items
comprising the QOLCE-55 are perceived similarly between
groups stratified by age and sex, as well as longitudinally
among individuals assessed at diagnosis and again
24 months later, thus providing evidence to support the
validity of the scale.
Full measurement equivalence was demonstrated through
to the level of strong invariance (item thresholds/factor
intercepts), and partial equivalence was demonstrated at the
level of strict invariance (item residuals/factor variances).
This finding is fundamental to establishing robust psychometric properties for the QOLCE-55. Previous research has
shown that nonequivalent item thresholds or intercepts have
large effects on the validity of mean scale comparisons
between groups, whereas item residual effects are negligible.33,34 This suggests that observed differences in
QOLCE-55 scores are real, and not an artifact associated
with performance of the scale or differential interpretation
of items between comparison groups (e.g., males vs.
females) or across repeated measurements over time.
Although strict invariance is required for defensible item
comparisons,23 such investigations are typically exercised
in psychometric analyses with minimal clinical relevance
for health professionals and children with epilepsy and their
families.
Of interest was the observation that the residuals associated with the Physical Functioning item—Played with
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Table 4. Tests of measurement equivalence over time
Configural invariance
no constraints
Weak invariance I
item factor loadings
Weak invariance II
first-order factors
Strong invariance I
item thresholds
Strong invariance II
first-order intercepts
Strict invariance I
item residuals
Strict invariance I
item residuals
(hCF1, hEF1, hEF12,
hEF15, hSF1, hSF2, hSF7, hPF1)
Strict invariance II
factor variances
Strict invariance II
factor variances (hSF)

v2 (df)

CFI

RMSEA (90% CI)

5,923.7 (2,858)

0.948

0.058 (0.056, 0.061)

5,943.1 (2,909)

0.949

0.057 (0.055, 0.059)

5,940.9 (2,912)

0.949

6,026.1 (3,066)

Dv2 (df)
–

DCFI

DRMSEA

–

–

72.4 (51)a

0.001

0.001

0.057 (0.055, 0.059)

2.9 (3)a

0.000

0.000

0.950

0.055 (0.053, 0.057)

208.3 (154)a

0.001

0.002

6,043.6 (3,070)

0.949

0.055 (0.053, 0.057)

18.3 (4)a

0.001

0.000

5,837.6 (3,125)

0.954

0.052 (0.050, 0.054)

198.1 (55)b

0.005

0.003

5,655.8 (3,117)

0.957

0.051 (0.049, 0.053)

81.5 (47)a

0.003

0.001

5,188.4 (3,122)

0.965

0.046 (0.043, 0.048)

25.8 (5)b

0.008

0.005

5,185.0 (3,121)

0.965

0.046 (0.043, 0.048)

17.7 (4)a

0.000

0.000

Italicized text describes the model parameters that were constrained at each step of the testing process. Constraints on the residuals of item 1 in each of the
Cognitive (CF1), Emotional (EF1), Social (SF1), and Physical Functioning (PF1) domains; as well as EF12, EF15, SF2, and SF7 were removed in model 7 and remained
unconstrained in subsequent models. In model 9, constraints on the variance of SF domain was removed to establish partial equivalence. aNot statistically significant; bp < 0.001.

friends away from you or your home?—were nonequivalent
in each model tested. This finding may be a function of the
interpretation of the term “played,” which can be quite
different for preadolescents where play may or may not be
equated with hanging out with friends or watching television compared to younger children where play may be
related to toys or games. This may also explain why
nonequivalence was observed in QOLCE-55 ratings over
time (baseline vs. 24-months later) as nearly one fourth of
our sample transitioned to preadolescence by the time of the
24-month follow-up. Likewise, the interpretation of play
could also include gender-related undertones, whereby boys
engage in more physically active play compared to girls.
Similarly, nonequivalent residuals associated with the
Cognitive Functioning item, Had trouble understanding
directions? and Emotional Functioning item, Felt no one
cared? were found for age-related tests of equivalence
(younger vs. older and longitudinal). This may be a function
of parental expectations in the maturation of cognitive abilities of children during childhood. Matching this development are increased environmental expectations and
demands on children in which cognitive difficulties may
become more apparent. That is, the type of directions that
younger children are expected to understand may be completely different from those in preadolescence, leading to
nonequivalence. There is also some evidence to suggest that
memory difficulties are associated with seizure type or epilepsy syndrome,35 and thus they could potentially contribute
to nonequivalence of the cognitive functioning item; how-

ever, there was no significant difference in the distribution
of seizure types between younger children and preadolescents with epilepsy in our sample. In a related vein, feelings
that no one cares, disconnectedness, or loneliness have been
shown to be related to a lack of close friends, peer rejection,
and victimization in older children and adolescents.36 Such
examples of stigmatization are commonly reported by children with epilepsy,37 which may become more apparent as
children mature through adolescence, thus contributing to
nonequivalence.
Moving forward, use of the QOLCE-55 and replication of
these findings in other samples of children with epilepsy is
encouraged. As well, tests of measurement equivalence
across cultural backgrounds and clinical aspects of epilepsy
(e.g., seizure type, epilepsy severity, IQ, cognitive or behavioral comorbidities) are warranted, as these represent constructs whereby important differences in the interpretation
of items comprising the QOLCE-55 could potentially
emerge. Tests of equivalence between informants (e.g.,
mother vs. father) are also needed, given that maternal and
paternal reports of child health and behavior often differ.38,39 The current study could not address these tests of
measurement equivalence due to: a lack of information on
the cultural background of participants and formal diagnoses of cognitive or behavioral problems; small counts for
specific seizure types (e.g., primary generalized, absence,
and benign epilepsy of childhood with rolandic spikes); and
few paternal informants (93% of informants were mothers).
These limitations are not unique to the current study, but
Epilepsia, 57(3):427–435, 2016
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reflect the current landscape of studies examining HRQoL
in children with epilepsy. It is likely that researchers will
need to pool data in an effort to achieve adequate statistical
power to investigate these tests of measurement equivalence
in the future. The QOLCE-55 is a parent-reported measure
and as a result our study cannot address the phenomenon of
child and parent discordance in reporting HRQoL in childhood epilepsy.40 To do so would require a test of measurement equivalence between child and parent reports.

Conclusion
In summary, these findings provide evidence of measurement equivalence of the QOLCE-55 across age, sex, and
time and contribute to its robust psychometric profile as a
valid and reliable measure of HRQoL in children with
epilepsy. Health professionals and researchers should be
confident that such group comparisons made using the
QOLCE-55 are unbiased and any differences detected are
meaningful and not related to differences in the interpretation of items by informants.
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